Sua seleção (0)
Detalhe da pesquisa
1.
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Blood;
134(11): 867-879, 2019 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31366621
2.
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.
Blood;
132(11): 1125-1133, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045838
3.
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
Blood;
131(4): 387-396, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196412
4.
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood;
131(25): 2816-2825, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724895
5.
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
Blood;
132(4): 393-404, 2018 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567798
6.
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant;
25(9): 1720-1729, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039409
7.
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
Cancer;
125(14): 2474-2487, 2019 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30920645
8.
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.
Cancer;
125(21): 3845-3852, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299106
9.
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
N Engl J Med;
375(8): 740-53, 2016 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27292104
10.
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Blood;
130(6): 722-731, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28588020
11.
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.
J Natl Compr Canc Netw;
17(5): 414-423, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085755
12.
Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling.
Br J Clin Pharmacol;
85(3): 590-600, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536405
13.
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin.
Am J Hematol;
94(4): 408-416, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623490
14.
Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE.
Cancer;
124(8): 1722-1732, 2018 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381191
15.
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers.
Br J Cancer;
118(11): 1425-1433, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765150
16.
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
16(9): 1108-1135, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181422
17.
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Am J Hematol;
93(11): 1301-1310, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30074259
18.
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.
Am J Hematol;
93(10): 1254-1266, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30058716
19.
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.
Am J Hematol;
93(2): 254-261, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29119643
20.
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia.
J Thromb Thrombolysis;
45(2): 306-314, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29260426